Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon | September 19, 2023 |

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis | June 25, 2021 |

Cracking the Code to Society’s Most Feared Disease

Even more so than cancer, it’s the one disease that we all fear the most. The thought of falling prey to Alzheimer’s disease and to the inevitable desecration of our mind is something that makes even the bravest among us shudder. ...
Marc Davis | February 7, 2020 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Ballard Power, NVIDIA, SolGold - copper, processors and fuel cells for the portfolio

The mobility of the future will be diverse. In addition to internal combustion engines, vehicles with electric motors will also define future everyday life. This politically motivated development will be supported by subsidies and premiums in various areas. Investors who would...
Mario Hose | August 27, 2020 |

Zynex Shares Trade Higher After Reporting a 95% Increase in Q3 Orders

Non-invasive medical device maker Zynex Inc's. shares are trading 12% higher on an overall down market day after the company reported that Q3/19 orders are up 95% over the same period in 2018. This morning medical technology company specializing in manufacturing and s...
Streetwise Reports | October 3, 2019 |

Drone Technology Company Is in the Limelight Amid Data Security Concerns

As worries over drone data take center stage, Red Cat Holdings' blockchain technology offers security and integrity of data. Drone data security has become a hot issue. The Department of the Interior last fall grounded its 1,000-strong drone fleet and in Jan...
Streetwise Reports | February 13, 2020 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Gold Demand Rose 7% in Q1 2019. A Launching Pad Higher for Gold?

In May, the WGC published a new edition of its quarterly report on gold demand. It features interesting data about the changes in gold demand and supply. What does the Gold Demand Trends Q1 2019 say about the gold market in the first quarter of the year? How will its concl...
Arkadiusz Sieron | May 21, 2019 |

Democrats Launch Formal Impeachment – What Should Traders Expect?

News of the formal impeachment proceedings came just after the markets closed on September 24, 2019. The markets had already broken a bit lower most of the day after Consumer Confidence and Jobs expectations were weaker than expected. We had just authored a public research pos...
Chris Vermeulen | September 27, 2019 |
1 2 3 4 5